Sale of shares
December 01 2010 - 2:00AM
UK Regulatory
TIDMMDY
RNS Number : 1219X
MDY Healthcare PLC
01 December 2010
MDY Healthcare plc
Sale of shares
Related party transaction
1 December 2010: MDY Healthcare plc ("MDY Healthcare" or the "Company"), the
strategic investor in healthcare companies,today announces that the Company has
sold part of its shareholding in SIW Holdings Limited ("Stanmore").
The Company has sold 600,000 A Preferred shares in Stanmore to Alan MacKay, a
former director of the Company, for a total cash consideration of GBP600,000
(the "Transaction"). The Company will use the proceeds of the sale of these
shares to fund the Company's ongoing operations, whilst continuing the review of
the best strategic options for the Company's key investments. The directors
have made good progress with the Company's cost reduction programme and
anticipate making further cost reductions in the future to conserve cash; these
will be detailed in the Company's year end results to be published in early
2011.
MDY Healthcare acquired 3,000,000 A Preferred shares (approximately 18% of the
current issued share capital of Stanmore on a fully diluted basis) in March
2008. In MDY Healthcare's last published accounts (for the year ended 30
September 2009), MDY healthcare held its investment in Stanmore at the original
investment cost of GBP3,000,000. Following the Transaction, MDY Healthcare holds
approximately 14.5% of the issued share capital of Stanmore and retains an
option to appoint a director to the board of Stanmore.
The sale of shares to Alan MacKay constitutes a transaction with a related party
for the purposes of rule 13 of the AIM Rules for Companies (the "AIM Rules") by
virtue of the fact that Alan MacKay is a former director of the Company. Alan
MacKay did not hold shares in Stanmore prior to the Transaction. In accordance
with the AIM Rules, the directors, having consulted with the Company's Nominated
Adviser, Brewin Dolphin Limited, consider that the terms of the Transaction are
fair and reasonable insofar as the Company's shareholders are concerned. In
advising the Board, Brewin Dolphin Limited has taken account of the directors'
commercial assessment of the Transaction.
For further information, please contact:
+------------------------------+------------------------------+
| MDY Healthcare plc | |
| Grahame Cook, Chairman | +44 (0) 207 647 1800 |
+------------------------------+------------------------------+
| | |
+------------------------------+------------------------------+
| Financial Dynamics | |
| Ben Atwell, Susan Quigley | +44 (0) 207 831 3113 |
+------------------------------+------------------------------+
| | |
+------------------------------+------------------------------+
| Brewin Dolphin Limited | |
| (Nomad) | +44 (0) 845 213 1000 |
| Matt Davis | |
+------------------------------+------------------------------+
Notes for editors:
About MDY Healthcare
MDY Healthcare plc is a sector specialised strategic investing company quoted on
AIM (ticker symbol: MDY). The Company seeks to achieve superior returns for
shareholders by investing globally in companies, both public and private, across
the healthcare sector. The directors and executive have significant operational
and investment experience in the sector and therefore the ability to identify
and review a wide range of potential investments. Further information can be
found on the website www.mdyhealthcare.com.
END
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCWGGAAGUPUGMU
MDY Healthcare (LSE:MDY)
Historical Stock Chart
From Jul 2024 to Aug 2024
MDY Healthcare (LSE:MDY)
Historical Stock Chart
From Aug 2023 to Aug 2024